• 2026 Participant Engagement Award Finalists Address Pediatric Patients; Lupus; Vaccine Trials; Recruitment Issues

    Dec 11 | Clinical Research News | Finalists have been announced in the 10th annual Participant Engagement Awards. Four projects from Biogen, Proximity Health Solutions, and BlackDoctor.org; Empath Labs; PACT; and Science 37 and RxE2 will be presented during a live judging session at SCOPE in Orlando, Florida, Feb 2-5, 2026. More

  • The Scope of Things: Practical Regulations Strategies for Clinical Efficiency

    Dec 09 | Clinical Research News | The FDA’s decades-old regulation 21 CFR Part 11—which establishes criteria for electronic records and signatures to be considered trustworthy and equivalent to paper records—is in dire need of an update. Doug Bain, founder and consulting partner of ClinFlo, has his own proposal on reformations to streamline clinical trials and improve experiences for patients, sites, and sponsors, which he discusses extensively in this month’s episode of the Scope of Things. More

  • Statistical Considerations in Decentralized Clinical Trials

    Dec 05 | Clinical Research News | Decentralized clinical trials (DCTs) aim to harness the power of technology to lower the burden of clinical trial participation, increase engagement and improve outreach and diversity. However, for these benefits to be realized, we need to understand the specific challenges created by DCTs and how to mitigate them. More

  • Next-Generation Immunotherapy Nears the Clinic with Dual Cancer Trials

    Dec 03 | Clinical Research News | Glycans are the complex sugar chains found at abnormally high levels on the surface of cancer cells—and one of the toughest challenges in cancer treatment. A research team from the UC Irvine School of Medicine developed glycan-dependent T cell recruiters (GlyTRs), which represent a first-of-its-kind approach that bypasses traditional antibody mechanisms to attack cancer’s sugar-coated armor. More

  • Space Health Research Could Rack Up Many Earthly Dividends

    Dec 02 | Clinical Research News | When the first all-civilian spaceflight, Inspiration4, was launched by SpaceX in 2021, it set into orbit the idea of future space habitation. It also marked the start of a long-term mission to understand the impact of the journey on everyday people without extensive astronaut training. More

  • Follow the Money: Hypertrophic Cardiomyopathy Therapeutic Candidate, Underserved Bleeding Disorders, Rare Disease Trials

    Nov 25 | Clinical Research News | Braveheart will advance their small molecule therapeutic candidate, BHB-1893, for hypertrophic cardiomyopathy; Hemab Therapeutics will keep developing sutacimig as the first-ever prophylactic treatment for Glanzmann thrombasthenia (GT); AAVantgarde will continue to work on their trials for treatments for Stargardt disease and Usher 1B; and more. More

  • Walgreens Launches New Patient Advisory Board, Advocate Health National Center for Clinical Trials Announced, P95, Julius Clinical Merge

    Nov 24 | Clinical Research News | Walgreens launches the Walgreens Pharmacy Patient Advisory Board; Advocate Health announces Advocate Health National Center for Clinical Trials, the U.S.’s first, largest, and most inclusive clinical trial network; P95 and Julius Clinical have merged to form a global, full-service clinical research organization; and more. More

  • Checking the Boxes for Expanding Trial Start-ups to New Countries

    Nov 21 | Clinical Research News | The patient-centered approach that has come into favor for planning and conducting clinical trials is, without question, improving care for trial participants. However, combined with other industry trends, including the proliferation of rare disease studies with much smaller patient pools, it is causing trial protocols to become more complex and is creating challenges in patient recruitment, which can lead to costly delays in a competitive and challenging macroeconomic environment. More

  • Early Rheumatoid Arthritis Studies Redefine Prevention and Clinical Research

    Nov 19 | Clinical Research News | Rheumatoid arthritis has a reputation as a lifelong condition with no real cure and can only be managed after symptoms appear. However, researchers from the Allen Institute for Immunology, University of California, San Diego, and the University of Colorado Anschutz, have mapped out a way to detect dramatic immune system changes before the joints start swelling. More

  • Pioneering Platform for Collecting ‘Home-Reported Outcomes’

    Nov 18 | Clinical Research News | As anyone contending with a complex chronic disease can likely attest, a lot has been “left on the table” when it comes to opportunities to achieve better health outcomes, lower costs, and greater personal satisfaction with their medical care. Tens of thousands of patients have voted for change by registering for the Folia Health app, which allows them to track their symptoms and share data about their own healthcare experiences with their care team or research studies. More
View more articles
 
DXX-Industry-spotlight
SOT

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

Read More